Introduction: Alcohol consumption is frequently associated with gastric mucosal lesions. The purpose of this study was to determine the effect of Coenzyme-Q 10 (CoQ 10 ) supplementation on the ethanol-induced gastric mucosal damage in a rat model. Material and method: Sixty-four female wistar albino rats were randomly divided into 8 groups (n = 8). Studies were performed in ethanol induced gastric ulcer model in Wistar albino rats. Famotidine at a dose of 5 mg/kg or 20 mg/kg and CoQ 10 at a single dose of 10 mg/kg or 20 mg/kg and 30 mg/kg for 7 days were administered as pretreatment. All the rats in study groups received 2 ml/kg ethanol 95 % intragastrically, 30 minutes after pretreatment. Four hour after ethanol administration, all rats were sacrifi ced and their stomachs were removed under ketamin anaesthesia. Gastric protection was evaluated by measuring the ulcer index, MDA concentrations, and histopathological studies. Results and discussion: Rats pretreated either with famotidine or CoQ 10 had signifi cantly diminished gastric mucosal damage which was assessed with gross and microscopic analysis (p < 0.00625). MDA levels were signifi cantly lower in famotidine 20 mg/kg and CoQ 10 pretreatment for 7 days group (p < 0.00625). Conclusion: CoQ 10 affords gastroprotection against ethanol-induced gastric mucosal lesions in rats especially after repetitive administrations (Tab. 3, Fig. 2, Ref. 35). Text in PDF www.elis.sk.
Coenzyme Q (CoQ), a 1,4 benzoquinone with a 50 carbon isoprenoid side chain, is an essential cofactor in the adenosine triphosphate generation via mitochondrial oxidative phosphorylation (1) . In addition, CoQ plays a role in inhibiting lipid peroxidation (2) . Various CoQ homologues exist, containing different numbers of isoprenoid units in the side chain. CoQ 9 and CoQ 10 are present in human plasma and both are equally effi cient as antioxidants and redox carriers (3) . CoQ 10 , the dominant form, is lipophilic and transported in the lipoprotein particles in circulation (4) . CoQ is synthesized in the body, and is also obtained from the diet, particularly by meat products (5) . Commercially available CoQ 10 preparations have been marketed for years. The reduced form of CoQ 10 is the only endogenously synthesized lipophilic antioxidant that serves to protect biological membranes against oxidation (6) .
The balance between aggressive and defensive factors determines the occurrence of gastric injury and the development of peptic ulcer. The invention of proton-pump inhibitors in anti-ulcer therapy had revolutionized treatment of peptic ulcers; nevertheless, the defi nitive cure for this disease process has not been established currently. Accordingly, the identifi cation of novel therapeutic agents with acceptable safety profi les, cost-effectivity and tolerable side effects are required.
Various experimental animal models have been performed to evaluate the gastro protective effects of different substances in literature (7) (8) (9) . Non steroid anti-infl ammatory agent and ethanol induced gastric injury models are two of the most preferred methods (10, 11) .
The aim of the present study was to evaluate the effects of CoQ 10 supplementation on ethanol-induced gastric mucosal injury in an experimental setting. The determination of gastroprotective action of the agent might shed some valuable light on the prevention and treatment of peptic ulcer disease.
Study design
The surgical procedure, use of anesthesia, and animal care methods in the experiments were consistent with the guidelines in the National Institute of Health's Guide for the Care and Use of Laboratory Animals (National Institutes of Health publication No. 86-23, revised 1985, Bethesda, MD) and were approved by the School of Medicine Ethics Committee of the Zonguldak Karaelmas University. The study was carried out on 64 female Wistar albino rats weighing 300-400 g. The rats were housed in a temperature controlled room (22-24 °C) and illumination (12:12 h light/dark-ness). All animals were fed with pellet food produced especially for experimental animals. Water was available ad libitum.
The experimental procedures were carried out in accordance with international guidelines for the use and care of laboratory animals. The drugs used in this experimental study (CoQ-10; Solgar Vit. & Herb, Leonia, NJ, USA, and Famoser, Biofarama İlaç San. Tic AŞ., Istanbul, Turkey) were purchased. The oral formulation of famotidine was dissolved in distilled water. CoQ 10 was dissolved in soybean oil. All drug solutions and suspensions were freshly prepared. All experiments were performed during the same time of the day to avoid diurnal variations of putative regulators of gastric functions. Gastric ulcers were infl icted by oral administration of ethanol 95 % at a dose of 2 ml/kg after 17 h starvation from 17 pm to 10 am.
The animals were allocated randomly into eight groups. Gastric lesions were induced using a model modifi ed from Mizui et al and Birdane et al (11, 12) . In Group 1 (saline; n = 8) rats received 2 ml/ kg of saline by gavage. Rats in Group 2 (ethanol, n = 8) received 2 ml/kg ethanol 95 %. The rats in group 3 (vehicle, n = 8) received 2 ml/kg soybean oil by gavage. The rats in group 4 (Famotidine 5, n = 8) and group 5 (Famotidine 20, n = 8) were pretreated with famotidine 5 mg/kg and 20 mg/kg, respectively. Rats in groups 6 (CoQ 10 10, n = 8) and group 7 (CoQ 10 20, n = 8) were pretreated with 10 mg/kg and 20 mg/kg CoQ 10 dissolved in soybean oil, respectively. The rats in group 8 (CoQ 10 7x30, n = 8) received CoQ 10 for 7 days at a dose of 30 mg/kg/d by gavage. Rats pretreated with vehicle, famotidine or CoQ 10 at different doses were given 2 ml/ kg ethanol 95 %, 30 minutes after pretreatment. All the animals completed the study protocol. Four hours after oral administration of ethanol all of the groups were anesthetized with intramuscular injection of 100 mg/kg Ketamin (Ketalar, Parke Davis-Eczacibaşi, Istanbul, Turkey). A midline abdominal incision was performed. All of the rats were sacrifi ced via cardiac puncture, and immediate gastrectomy was performed. Subsequently, each stomach was incised along the greater curvature and rinsed in ice-cold distilled water, after which it was pinned out on a wax platform. Macroscopic damage to the gastric mucosa was assessed. Hemorrhagic and ulcerative lesions were counted and their lengths measured on square millimeter paper. Gastric mucosal lesions were expressed as the sum of the lengths (mm) of all lesions for each stomach and it was used as the Ulcer Index (UI) (7, 13, 14) . Gastric lesions were evaluated by two independent researchers blinded to the study protocol. Mean score of the two independent observers were taken into account, and the sum of the total scores was divided by the number of animals to obtain the mean UI for each group.
The stomach of each animal was divided into two equal parts for histopathologic and biochemical analysis. One part of the stomach was excised and immersed in saline and was immediately stored at -40 °C for measurement of malondialdehyde (MDA) levels. The other part of stomach was fi xed in 10 % neutral formalin.
Biochemical analysis
Gastric tissues were homogenized in ten volumes of 150 mM ice-cold KCl using a glass tefl on homogenizer (Ultra Turrax IKA T18 Basic) after cutting the tissues into small pieces with scissors (for 2 min at 5000 rpm). The homogenate was then centrifuged at 5000×g for 15 min. The supernatant was used for analysis. High performance liquid chromatographic analysis was performed with isocratic method using a Shimadzu HPLC system (Kyoto, Japan) using a commercial MDA kit (Immundiagnostik AG, Bensheim, Germany). The fi rst step in determining MDA is a sample preparation with derivatization reagent transforms MDA into a fl uorescent product. Afterwards, the pH was optimized and reaction mixture (20 ml) was then on a reversed phase C18 column (18.5 mm, 125x4 mm) at 30°C. The fl ow rate was 0.8 ml/min. Fluorimetric detection was performed with excitation at 515 nm and emission at 553 nm. The detection limit was 0.15 mmol/L and linearity was up to 100 mmol/L. Total protein in the extracts and supernatants was determined by the method of Fujita et al (15) on Advia 2400 autoanalyser (Siemens, Tarrytown, NY, USA). Results were expressed nmol/g protein for MDA.
Histopathological analysis
The samples for histology were dehydrated and embedded in paraffi n and cut into 5 μm sections. The sections were stained with hematoxylin and eosin (H&E) and examined under the light microscope for histological changes by a blinded pathologist. Histological evaluation was performed on the glandular stomach of animals. Gastric mucosal injury was assessed semi-quantitatively using the previously described histopathological changes such as ulceration, hemorrhage, focal necrosis, mucosal congestion, glandular cell degeneration, infl ammation, and edema. Microscopic scoring of the tissue samples was performed on a scale ranging from 0 to 3 (0: None, 1: Mild, 2: Moderate, 3: Severe) (16, 17) . Histopathological score for each group was determined as the sum of the scores for each parameter (Tab. 1).
Power analysis
Sample size estimation was based on the standard deviation in a similar study performed by Arun et al (17) . To use the Ulcer Index (7.70 ± 0.54) determined by Arun et al (17) from their previous study of ethanol induced gastric ulcer on rats, ( in order to detect a 5 % change in ulcer index, with an alpha error of 0.05 and a power of 80 %), calculated sample size should be at least 8 rats per group.
Statistical analysis
The statistical analysis was performed using Statistical Package for the Social Sciences (SPSS) version 12.0 for Windows. All data are expressed as mean ± SD. Mann Whitney U test with Bonferroni correction were used for statistical analysis of data in all groups. Our study consists of 8 groups, after Mann-Whitney U test with Bonferroni correction, p < 0.00625 was considered as statistically signifi cant.
Results
The acute gastric lesions were induced by the intragastric administration of 2 ml/kg of 95 % ethanol. There was no statistically signifi cant difference in mean body weights between groups. Macroscopic analysis demonstrated ethanol (2 ml/kg) induced ulcer formation in all stomachs except sham group. Gastric mucosal damage was found to be reduced by famotidine and CoQ 10 pretreatment, dependent of the dose administered. Famotidine 20 mg/kg and CoQ 10 administered for a week at a dose of 30 mg/kg has revealed most potent gastroprotective effect against ethanol induced gastric mucosal damage when compared to sham group (p = 1 and p = 0.1, respectively).
Soybean oil administration as a vehicle of CoQ 10 has reduced gastric damage. In vehicle group, the mean count of ulcerations and the UI were both determined to be lower than the ethanol group. In vehicle group diminished UI were observed, however, it reached no signifi cance (p > 0.00625). Macroscopic evaluations of the gastric damage are presented in Table 2 .
In damaged stomachs, mucosal lesions with different size and forms were dispersed to all stomach surfaces. Those lesions consisted of elongated bands parallel to the long axis of the stomach. The interobserver variations for ulcer count and ulcer area were found to be 3.1 %, and 4.6 %, respectively. Lesions of the gastric mucosa in each group are shown in Figure 1 .
MDA, a quantitative marker of lipid peroxidation, was measured in the gastric tissues. MDA levels were found to be higher in ethanol group than in the other groups. There were signifi cant differences between ethanol and the other groups in respect to tissue MDA levels (p < 0.00625). MDA levels for each group are shown in Table 3 .
Ethanol group had the highest histopathological score of gastric mucosal damage, and famotidine 20 mg/kg and CoQ 10 7x30 mg/kg groups achieved the lowest histopathological score. Soybean oil and single dose of CoQ 10 administration have partial gastroprotective effect proved in histopathological evaluation. Details of the histopathological evaluations are shown in Table  1 . Microscopic views of the normal and damaged gastric mucosa are shown in Figure 2 .
Discussion
Ethanol-induced gastric ulcers have been widely used for the evaluation of gastroprotective activity of several compounds. In experimental ethanol induced gastric injury models different volumes of ethanol in different concentrations had been applied. Some authors administered absolute ethanol, whereas the others administered ethanol in lower concentrations up to 40 % (9, 11, (17) (18) (19) (20) (21) (22) . In the present study, the administration of 95 % ethanol with a dose of 2 ml/kg by gavage was selected to induce gastric injury. Alcohol related gastric injury in humans is mostly a result of chronic exposure at a lower concentration. Nevertheless, gastroprotective effects of various compounds are mostly examined in experimental rat models with a single dose of ethanol administration. Accordingly, single dose of ethanol was selected for the present study. Long term administration of ethanol is another option to be studied, as performed by Li et al (23) . Ethanol induced gastric injury models possess various limitations, including the differences between the doses and concentrations of ethanol that is preferred by authors. Consequently, the results gathered from the single dose ethanol induced gastric injury models need to be correlated with the chronic administration, before being refl ected to human subjects. The authors of the present study preferred to administer ethanol in a high concentration, but in low-median volumes used in the literature (17) (18) (19) (20) (21) (22) .
The pathogenesis of ethanol-induced gastric ulcer production in animals is multifactorial, involving superfi cial aggressive cellular necrosis as well as the release of superoxide anion and hydroperoxy free radicals by the metabolism of ethanol in the body (24) . These mediators decrease gastric microvascular blood fl ow, triggering a series of events that lead to gastric tissue damage (25) . Besides prostaglandins, L-Arginine /nitric oxide (NO) pathway is a major protective system in gastric mucosa via relaxation of the arterial smooth muscles. Vasodilatation is important in the maintenance of gastric integrity, by means of blood fl ow enhancement, preventing the activation of infl ammatory factors and removing irritants (26) . Ethanol, on the other hand, alters the gastric mucosal barrier by its disorganizing effects on gastric surfactants (27) .
Historically, there were many products of natural sources with gastroprotective properties. The gastroprotective effect of CoQ 10 and soybean oil, as a vehicle, was examined in this experimental rat study. Diary foods have gastroprotective effects against stress induced gastric damage in rat. Dietary fats reduce secretion of gastric juice mediated by GIP (28) . Commercially available oil preparations contain CoQ either dominantly in CoQ 9 or CoQ 10 (29) . Lipid compounds also act as a surfactant and maintain surface hydrophobicity, which is reduced by ulcerogenic agents (30) . Those properties of lipid compounds protect gastric mucosa against harmful effects of ethanol. We observed that soybean oil has partial gastroprotective effect against ethanol induced gastric damage itself. Gastroprotective effect of soy-bean oil (vehicle) was found similar to the single dose of CoQ 10 administr ation. It was signifi cantly lower than that of repetetive administration of CoQ 10 . Zhang et al (29) found out that the oil itself did not make any signifi cant difference in hepatic CoQ concentrations in their experimental study. They also showed that total CoQ concentration of the liver was time (administration period) dependent. Interestingly, administration of CoQ 10 did not suppress endogenous CoQ 9 synthesis. Even with as little as 0.3 μmol CoQ 10 /100g body weight for 4 days was found to be suffi cient for doubled tissue CoQ 10 concentration (29) . Although, Zhipeng et al reported that, CoQ 10 was well tolerated by rats at higher doses, literature lacks any other study determining CoQ concentration in gastric tissues in an experimental gastric ulcer model (31) . Consequently, the determination of CoQ levels in gastric tissues should be evaluated in further studies of ulcer models. Gastroprotective effects of soybean and single dose of CoQ 10 are not potent. It is stated that it is impossible to achieve suffi cient tissue concentration with a single dose of CoQ administration. Accordingly, repetitive and successive doses of CoQ administration lead to an increase in tissue concentration which in turn over expresses the protective effect of CoQ (30) . Consistent with the literature, upon treatments of rats in group 8 for 7 days with CoQ 10 dissolved in soybean oil, we observed signifi cant gastro-protection. CoQ 10 was administrated for 7 days in higher doses to get at least 100 % increase in tissue CoQ concentration. Gastroprotective effect in group 8 pretreated with 30 mg/kg CoQ 10 f or 7 days shows the affect of repetitive CoQ 10 administration. The lack of animal group pretreated with a single dose of 30 mg/kg BW CoQ 10 is a short arm of this study. Our present study reveals that repeated doses of exogenous CoQ 10 administration provide signifi cant gastroprotection in an experimental model of gastric injury induced by ethanol administration.
CoQ 10 has been shown to correlate positively with body mass index (32) . All the rat groups in our study were comparable with the other groups in respect to mean body weights.
It's a well-known fact that CoQ plays several crucial roles in the body, acting as an essential antioxidant, infl uencing the stability of membranes, and acting as a redox electron carrier in the mitochondria (33) . Moreover, anti-tumour effect of CoQ 10 administration has also been demonstrated (34) . Nevertheless, the gastroprotective effect has not been clarifi ed up to date. In the present study, the protective effect of CoQ 10 against ga stric mucosal damage induced by ethanol consumption is determined, particularly after consecutive daily administrations. Possible mechanisms of gastroprotection attributed to the CoQ 10 administration might be as follows: it can act as an antioxidant directly protecting biological membranes against oxidation (4), the antioxidant effect of CoQ species might balance the overproduction of reactive oxygen species by the metabolism of ethanol, CoQ 10 may counte ract vasoconstriction resulting from impaired endothelial nitric oxide production (35) , and CoQ 10 might maintain gastric mucus thickness.
H 2 blockers and proton pump inhibitors are gastroprotective and anti-ulcerogenic drugs commonly used worldwide. Gastroprotective effects of these drugs are signifi cantly greater when given in high doses. The results of our experimental study either with low or high doses of H 2 blockers were found to be in accordance with the literature. Widespread use of H 2 blockers could not prevent peptic ulcer related disorders. Therefore, the search for new alternatives with novel mechanisms of action is ongoing. In this study, we compared gastroprotective effect of CoQ 10 with those of famotidine as standard treatment option Histopathological analysis showed that ethanol administration caused gastric mucosal injuries characterized by hemorrhage, mucosal edema, epithelial cell loss, and infl ammatory cell infi ltration, in accordance with previous studies (9, 18) . The lowest histopathological score was observed with Famotidine 20 mg/kg and CoQ 10 given at 30 mg/kg doses for 7 days. The highest histopathological score was observed in the ethanol group. These results revealed that the pretreatment with famotidine and CoQ 10 administration diminished gastric mucosal damage. Famotidine has a dose dependent gastroprotective effect, and CoQ 10 leadsto a signifi cant gastroprotection with a 7 days course of repetitive administration. On the other hand, single dose of CoQ 10 administration, even in high doses, did not achieve gastroprotective effect better than the vehicle.
Conclusion
The present study revealed that oral CoQ 10 pretreatment in repetitive doses for 7 days signifi cantly reduces gastric mucosal injury related to the ethanol application. Soybean oil and single dose of CoQ 10 possess weak gastroprotective potential. Further studies are required to determine the underlying physio-pathological mechanisms that are responsible for the gastroprotective effect of oral CoQ 10 administration.
